Previous 10 | Next 10 |
COVID-19 test and therapy developer Ainos ( OTCPK:AIMD ) conducted a reverse stock split, uplisted its stock to Nasdaq and held a downsized $3M initial public offering on Tuesday. Ainos offered 780K units at $4.25 per unit, raising around $3.3M. Each unit consisted of one sh...
Ainos ( OTCPK:AIMD ) has priced its underwritten public offering of 780K units at a public offering price of $4.25/unit for expected gross proceeds of ~$3.3 million. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of...
SAN DIEGO, CA / ACCESSWIRE / August 8, 2022 / Ainos, Inc. (OTC PINK:AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced th...
Drug and medtech developer Ainos ( OTCPK:AIMD ) has updated its financial disclosures for a proposed public offering and uplisting to Nasdaq. In its most recent filing , Ainos reported a net loss of $2.1M on revenue of $87K for the quarter ended March 31, 2022. The company a...
Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19 PR Newswire Hamsters Receiving Ainos' VELDONA Formulation Demonstrate Protection from COVID-19 Based on Prespecified Indicators of Clinical Outcomes ...
SAN DIEGO, CA / ACCESSWIRE / June 21, 2022 / Ainos, Inc. (OTC PINK:AIMD) ("Ainos", or the "Company"), a diversified medtech company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced tha...
SAN DIEGO, CA / ACCESSWIRE / December 7, 2021 / Ainos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), a diversified healthcare company engaged in the discovery and development of pharmaceutical, medical devices and biotech products announced it entered into a Development and Sales Ag...
SAN DIEGO, CA / ACCESSWIRE / November 3, 2021 / Ainos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), announced today that the company has recently achieved early stage milestones in its mRNA vaccine research and development initiative. The company's mRNA vaccine is designed against ...
SAN DIEGO, CA / ACCESSWIRE / August 16, 2021 / Ainos, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), elected Ms. Hui-Lan (Celia) Wu as its new Chief Financial Officer ("CFO"). Ms. Wu succeeds Mr. Chun-Hsien Tsai who resigned from his CFO position but continues to serve as the Company...
Ainos ([[AIMD]] -3.1%) has entered into an exclusive agreement to serve as the master sales and marketing agent for the Ainos SARS-CoV-2 Antigen Rapid Test Kit for Taiwan Carbon Nano.The kit uses an antigen rapid test technology jointly developed by Taiwan's National Health Research...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results, paving the way for next-gen product targeting at-home testing Next-Gen Ainos Flora will advance with NVIDIA CUDA, targeting Q3 for design completion and Q4 for clinical trial kickoff ...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...